Literature DB >> 10660489

Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.

G Pluijm1, C Löwik, S Papapoulos.   

Abstract

Breast cancer metastasizes frequently to the skeleton and causes considerable morbidity and deterioration of the quality of life. The clinical consequences of skeletal metastases are bone pain, pathological fractures, hypercalcaemia and nerve compression syndromes. From the moment breast cancer cells are located in the bone microenvironment, they may release factors which stimulate bone resorption and angiogenesis leading to growth of skeletal metastases and a subsequent selective increase in the attraction of new cancer cells to bone. In this review, emerging new concepts of breast cancer-bone interactions, in particular the involvement of angiogenesis, proteolysis and the role of cancer-induced bone resorption in skeletal metastasis are discussed. Better understanding of the processes involved in the metastasis of cancer cells to bone, local tumour growth and subsequent destruction of skeletal architecture can lead to optimal methods for the prevention and treatment of metastatic bone disease.

Entities:  

Mesh:

Year:  2000        PMID: 10660489     DOI: 10.1053/ctrv.1999.0143

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  9 in total

1.  Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.

Authors:  G van der Pluijm; B Sijmons; H Vloedgraven; C van der Bent; J W Drijfhout; J Verheijen; P Quax; M Karperien; S Papapoulos; C Löwik
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

Authors:  Ahmed Boucharaba; Claire-Marie Serre; Sandra Grès; Jean Sébastien Saulnier-Blache; Jean-Claude Bordet; Julien Guglielmi; Philippe Clézardin; Olivier Peyruchaud
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 3.  The role of bisphosphonates as adjuvant therapy for breast cancer.

Authors:  J R Gralow
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

4.  N-Telopeptide of Type I Collagen Long-Term Dynamics in Breast Cancer Patients With Bone Metastases: Clinical Outcomes and Influence of Extraskeletal Metastases.

Authors:  Arlindo R Ferreira; Irina Alho; Ning Shan; Margarida Matias; Mariana Faria; Sandra Casimiro; Kim Leitzel; Suhail Ali; Allan Lipton; Luís Costa
Journal:  Oncologist       Date:  2016-08-17

5.  Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer.

Authors:  T Skrinskas; M Clemons; O Freedman; I Weller; C M Whyne
Journal:  Clin Exp Metastasis       Date:  2008-10-22       Impact factor: 5.150

Review 6.  Multimodal imaging and treatment of bone metastasis.

Authors:  Eric L Kaijzel; Thomas J A Snoeks; Jeroen T Buijs; Gabri van der Pluijm; Clemens W G M Löwik
Journal:  Clin Exp Metastasis       Date:  2008-10-22       Impact factor: 5.150

7.  Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer.

Authors:  Jenny Lin; Leanne Goldstein; Amanda Nesbit; Mike Y Chen
Journal:  World Neurosurg       Date:  2015-08-07       Impact factor: 2.104

8.  Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.

Authors:  Joachim Diessner; Manfred Wischnewsky; Tanja Stüber; Roland Stein; Mathias Krockenberger; Sebastian Häusler; Wolfgang Janni; Rolf Kreienberg; Maria Blettner; Lukas Schwentner; Achim Wöckel; Catharina Bartmann
Journal:  BMC Cancer       Date:  2016-05-12       Impact factor: 4.430

9.  Clinicopathologic features of single bone metastasis in breast cancer.

Authors:  Murat Karatas; Baha Zengel; Raika Durusoy; Funda Tasli; Zehra Adibelli; Cenk Simsek; Adam Uslu
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.